Smartleaf Asset Management’s Privia Health PRVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$255K Sell
12,714
-1,681
-12% -$37.9K 0.01% 707
2025
Q4
$343K Buy
14,395
+1,997
+16% +$48.6K 0.01% 614
2025
Q3
$303K Buy
12,398
+3,373
+37% +$72.6K 0.02% 599
2025
Q2
$199K Sell
9,025
-35
-0.4% -$810 0.02% 578
2025
Q1
$205K Buy
9,060
+1,785
+25% +$41.5K 0.02% 561
2024
Q4
$142K Buy
7,275
+3,779
+108% +$74.9K 0.01% 678
2024
Q3
$63.2K Buy
3,496
+656
+23% +$12.5K 0.01% 840
2024
Q2
$48.6K Buy
2,840
+325
+13% +$5.76K 0.01% 751
2024
Q1
$49.2K Sell
2,515
-5
-0.2% -$106 0.01% 679
2023
Q4
$60.3K Buy
+2,520
New +$56.4K 0.02% 512

Other funds holding PRVA

Smartleaf Asset Management's PRVA Position: Q1 2026 in Review

Smartleaf Asset Management reduced its Privia Health (PRVA) stake by 12% in Q1 2026, selling an estimated $37.9K and leaving 12,714 shares worth $255K. The position accounts for 0.01% of the portfolio, ranked #707.

Smartleaf Asset Management first reported a position in PRVA in Q4 2023 and has held it in 10 quarters since. The position peaked at $343K in Q4 2025. 293 funds tracked by Wall St. Rank hold PRVA as of Q1 2026.

  • Smartleaf Asset Management held 12,714 shares of Privia Health worth $255K as of Q1 2026.
  • Smartleaf Asset Management sold 1,681 Privia Health shares in Q1 2026, an estimated $37.9K.
  • Privia Health made up 0.01% of Smartleaf Asset Management's portfolio in Q1 2026, its #707 holding.
  • Smartleaf Asset Management first reported a position in Privia Health in Q4 2023 and has held it in 10 quarters since.
  • Smartleaf Asset Management's Privia Health position peaked at $343K in Q4 2025.
  • 293 funds tracked by Wall St. Rank held Privia Health as of Q1 2026.

Based on Smartleaf Asset Management's 13F filing for Q1 2026, filed 15 May 2026.